Labcorp receives fda emergency use authorization for mpox pcr test home collection kit

The first at-home mpox testing kit provides patients with convenience and privacy to test for mpox, supports physicians in detection and treatment burlington, n.c. , april 10, 2024 /prnewswire/ -- labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, announced today the u.s. food and drug administration (fda) has granted emergency use authorization (eua) for its mpox  pcr test home collection kit to aid in the diagnosis of infection with non-variola orthopoxvirus, including the monkeypox virus that causes monkeypox, also known as mpox.
LH Ratings Summary
LH Quant Ranking